Skip to main content
Year archive

HVIVO PLC — 2025 filings

All 40 regulatory filings released by HVIVO PLC (HVO) in 2025, sourced directly from the official regulator.

40 Filings
2025 Period
2025 filings (40)
Filing Released Lang
Appointment of Non-Executive Director
Board/Management Information
2025-12-18 English
CEO & CFO Share Purchase
Director's Dealing
2025-12-15 English
MSD to acquire Cidara
M&A Activity
2025-11-27 English
>£5 million CRS contracts signed
Regulatory Filings
2025-11-20 English
Positive data from novel human challenge models
Regulatory Filings
2025-11-11 English
Holding(s) in Company
Major Shareholding Notification
2025-11-06 English
Presentation at Jefferies Healthcare Conference
Regulatory Filings
2025-11-03 English
Holding(s) in Company
Major Shareholding Notification
2025-10-27 English
Interim results
Interim / Quarterly Report H1 2025
2025-09-23 English
Notice of Results
Report Publication Announcement
2025-09-04 English
Appointment of Non-Executive Chair
Board/Management Information
2025-09-01 English
Proposed appointment of Chair
Board/Management Information
2025-07-29 English
H1 Trading update
Earnings Release H1 2025
2025-07-22 English
Directorate Change
Board/Management Information
2025-07-18 English
Notice of Trading Update
Regulatory Filings
2025-07-09 English
Holding(s) in Company
Major Shareholding Notification
2025-07-01 English
Positive results from client Phase 2b field study
Earnings Release H1 2025
2025-06-30 English
Result of AGM
AGM Information
2025-06-05 English
Director/PDMR Shareholding
Director's Dealing
2025-06-02 English
Group of companies' accounts made up to 2024-12-31
Regulatory Filings
2025-06-02 English
Trading update
Regulatory Filings
2025-05-30 English
Appointment of Independent Non-Executive Director
Board/Management Information
2025-05-29 English
Annual Report, Notice of AGM & Directorate Change
AGM Information
2025-05-12 English
Exercise of Options
Director's Dealing
2025-04-10 English
Final results
Earnings Release FY 2024
2025-04-10 English
AIM Rule 17 and Schedule 2(g) Update
Board/Management Information
2025-03-26 English
Notice of Results
Report Publication Announcement
2025-03-21 English
Director/PDMR Shareholding
Director's Dealing
2025-03-07 English
Acquisition of Cryostore for up to £3.2m
M&A Activity
2025-02-27 English
£2m hMPV characterisation study contract
Regulatory Filings
2025-02-17 English
Shionogi reports positive RSV trial results
Legal Proceedings Report
2025-02-05 English
RSV contract signed with Inhalon Biopharma
Regulatory Filings
2025-02-03 English
Holding(s) in Company
Major Shareholding Notification
2025-01-31 English
Holding(s) in Company
Director's Dealing
2025-01-31 English
Acquisition: two Clinical Research Units from CRS
Earnings Release FY 2024
2025-01-29 English
Trading update
Earnings Release FY 2024
2025-01-29 English
LOI signed for Phase 3 Whooping Cough trial
Regulatory Filings
2025-01-27 English
£3.2m hLAB project
Regulatory Filings
2025-01-21 English
Holding(s) in Company
Major Shareholding Notification
2025-01-14 English
hMPV challenge model update
Regulatory Filings
2025-01-13 English